Update on septic shock: The latest approaches to treatment - How new treatment modalities may improve outcomes

Journal of Critical Illness

Volumn 18, Issue 4, 2003, Pages 162-168

  Cruz, Kenneth ^a   Hollenberg, Steven ^b,c  

^a Northwest Community Health Care   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; DROTRECOGIN; ENDOTOXIN ANTIBODY; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYPERTENSIVE AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INOTROPIC AGENT; INTERLEUKIN 1 ANTIBODY; MILRINONE; MONOCLONAL ANTIBODY; NORADRENALIN; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASOPRESSIN;

ANTIBIOTIC THERAPY; DISEASE COURSE; EARLY DIAGNOSIS; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HEART ATRIUM ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; HYPOVOLEMIA; INOTROPISM; OUTCOMES RESEARCH; PATIENT SELECTION; RESUSCITATION; REVIEW; SEPTIC SHOCK; SURGICAL DRAINAGE; TACHYCARDIA;

EID: 0037392324     PISSN: 10400257     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia, IV: re-evaluation of clinical features and treatment in 612 patients. Am J Med. 1980;68:344-355.
2. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474.
3. Reynolds HN, Haupt MT, Thill-Baharozian MC, Carlson RW. Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA. 1988;260:3446-3450.
4. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
5. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Crit Care Med. 1999;27:639-660.
6. Packman M, Rackow EC. Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med. 1983;11:165-169.
7. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999; 27:200-210.
8. Hebert PC, Wells G, Blajchman MA, et al. A multicenter randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409-417.
9. Corwin HL, Gettinger A, Rodriguez RM, et al. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med. 1999;27:2346-2350.
10. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.
11. Grover R, Lopez A, Lorente J, et al. Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock [abstract]. Crit Care Med. 1999;27(suppl 1):A33.
12. Annane D, Sébille V, Troché G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000;283: 1038-1045.
13. Molijn GJ, Spek JJ, van Uffelen JC, et al. Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock. J Clin Endocrinol Metab. 1995;80: 1799-1803.
14. Briegel J, Kellermann W, Forst H, et al. Low-dose hydrocortisone attenuates the systemic inflammatory response syndrome. Clin Investig. 1991;72:782-787.
15. Annane D, Bellissant E, Sébille V, et al. Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve Br J Clin Pharmacol. 1998;46:589-597.
16. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26:645-650.
17. Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871.
18. Wilson MF, Brackett DJ, Tompkins P, et al. Elevated plasma vasopressin concentrations during endotoxin and E coli shock. Adv Shock Res. 1981;6:15-26.
19. Landry DW, Levin HR, Gallant EM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95:1122-1125.
20. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001; 120:989-1002.
21. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25:1279-1282.
22. Thijs LG, de Boer JP, de Groot M, Hack CE. Coagulation disorders in septic shock. Intensive Care Med. 1993;19(suppl 1):S8-S15.
23. Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiologic anti-coagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med. 2001;29(suppl 7):S90-S94.
24. Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest. 1992;101:816-823.
25. Fisher CJ, Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med. 2000; 28(suppl 9):S49-S56.
26. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
27. Hollenberg SM, Parrillo JE. Surgical Intensive Care. New York: Little-Brown; 1993.
28. Parrillo JE. Cecil's Textbook of Medicine. Philadelphia: WB Saunders Co; 2000: 503.